Abstract. This article is intended to explore the influence of institutional investors' holding ratio on enterprises' innovation, considering R&D inputs as the intermediate variable. In the study, 658 samples from manufacturing and information technology industry in Growth Enterprise Market in 2012-2014 were identified as research objects. Multivariate regression models were established and regression analysis was conducted by SPSS. The empirical results revealed that the institutional Investors' overall holdings ratio had the forward influence on corporate R&D and innovation ability, but the regression coefficients are not high; pressure-resistance institutional shareholders' holdings ratio had the significant positive influence on corporate R&D, while the innovation ability was not significant; the pressure-sensitive institutional investors have no significant impacts on corporate R&D investment and innovation ability of enterprises; the current R&D intensity has no significant effect on the one-period lag innovation ability of the enterprise.
Introduction
Innovation is the embodiment of national wisdom and autonomy. With the accelerated pace of global economic integration, the world economy is changing profoundly. International competition is growing fierce in the aspect of import and export trade, national defense, science and technology, medical treatment and so on. The enterprise is the national economy cell, the corporate R&D investments are not only related to individual innovation, but also affect the entire country's innovation ability.
In the 90's of the last century，it has been a major trend in investor institutionalization. Institutional investors began to grow at a comparatively high speed in western developed countries, and participated in corporate governance with the sense of ownership. Western institutional investors were increasingly becoming an external tool for "stable capital markets" and "corporate governance".
China institutional investors came true relatively late. In 2000, China Securities Regulatory Commission proposed large-scale development of institutional investors, hoping that the development of institutional investors would contribute to the stability of the capital market. Under the impetus of the government, institutional investors in China have achieved long-term development in terms of size, type and stock holdings.
Literature Review
Since 1990s, many scholars have researched deeply on the relationship between institutional investors and R&D. And inductively, there are three conflicting views on the impact of institutional shareholders on R&D investments.
One is the institutional investor activism theory. The principle implies that institutional investors will promote the company's R&D investments. Black (1992) supported that institutional shareholders can get a more overall market information before the investment decision, and thus have a motivation to comprehensively evaluate the long-term benefits of research and development projects, compared with individual investors [1] . Wahal and McConnell (2000) and Aghion (2009) confirmed this view [2, 3] .
The second theory is institutional investor myopia theory. The principle implies that institutional investors will pay more attention to short-term interests and inhibit R&D behavior. Institutional investors are "traders", not the "owner" of the enterprise, so they highlight on short-term gains. Driven by pressure, managers have to consider the growth of short-term revenue as the first goal. David et al. (2006) employed empirical study and also validated the negative relationship between institutional ownership and corporate R&D investments [4] .
The last opinion is the neutral theory. The theory suggests the impact of institutional shareholders on corporate R&D activities is very small, even negligible. Institutional investors use the Bayesian Rule to make decisions. Hansen & Hill (1991) made a rational judgment on employing all the potential future cash flow of the company's public available information [5] .
At present, foreign scholars have conducted plenty of researches and have acquired some primary conclusions. The present researches mainly focus on the relationship between institutional investors and corporate R&D. However, the increase in R&D spending is not equal to the improvement of enterprise innovation capability. In order to improve the competitiveness of enterprises, it is of practical significance to study the impact of institutional investors on corporate R&D expenditure and then to study the impact of institutional investors on the innovation ability of enterprises.
Method

Hypothesis
Corporate R&D activities have protracted nature, obvious hysteresis effect and the high rate of return. Retail shareholders may pursue short-term interests and inhibit corporate R&D activities, while institutional shareholders, as more foresighted investors, compared with the retail shareholder pay attention to the enterprise value investment and long-term investment. Therefore, hypothesis 1 was put forward:
H1: The overall ownership of institutional investors has a positive effect on corporate R&D spending.
Pressure-resistance institutional shareholders participated in corporate governance independently and effectively in the absence of potential business association. While, pressure-sensitive institutional shareholders had some concerns in the process of external supervision to maintain the commercial relationship with target enterprises. So hypothesis 2a and 2b were proposed:
H2a: Pressure-resistance institutional shareholders promote corporate R&D activities H2b: Pressure-sensitive institutional shareholders had no significant influence on R&D behaviors.
Enterprises' R&D spending was not equivalent to innovation capability for R&D expenditure probably became the sunk cost, and the innovation ability depended on the manager's tolerance for failure. Further assumptions were put forward:
H3: The overall ownership of institutional investors has a positive effect on corporate innovation ability H4a: Pressure-resistance institutional shareholders promote corporate innovation ability H4b: Pressure-sensitive institutional shareholders had no significant influence on corporate innovation capability
Variables
Corporate investments density of research and development activity (RDI) and innovation ability (INO) were considered as independent variables. 0ne-period lag proportion of R&D investment and annual operating income were representative of RDI, and one-period lag patent applications were chosen to represent INO.
Institutional ownership proportion (RIO), pressure-resistance institutional shareholders' holdings ratio (RIOres) and pressure-sensitive institutional shareholders proportion (RIOsen) were identified as dependent variables. RIO include in securities investment funds, insurance funds, social security funds, securities companies, trust companies, qualified foreign institutional investors (QFII) and other institutional shareholders. Securities investment funds, social security funds and qualified foreign institutional investors (QFII) were enrolled in RIOres. Insurance funds, securities companies, trust companies and financial companies were regarded as pressure-sensitive institutional investors. Controlled variables contained enterprise scale (SIZE), Asset liability ratio (LEV), Enterprise growth (GROW), Cash liquidity (FCFZ), Income level (ROE), industry and year variables.
Models
According to the four hypotheses, six models were designed to verify the validity of the hypothesis respectively: 
Model 1 was used to validate the impact of institutional investors' overall shareholding on firm R&D investment that is hypothesis 1. Model 2 and model 3 were derived from model 1, and respectively designed to validated hypothesis 2a and 2b. Model 4 were used to confirm hypothesis 3. As for hypothesis 4a and 4b, model 5 and 6 were appropriate.
Data collection
The company that list companies' R&D investments has industry sensitivity. The manufacturing and information technology industry account for more than 80 percent. For the continuity and discretion of samples, the companies that possessed institutional shareholders, R&D investments and patents for three years were taken into account. So enterprises of manufacturing and information technology industry were enrolled in this investigation, which issued A shares and announced R&D investments in the GEM market in 2012-2014 years.
As for company's R&D investments intensity, director reports of listed companies were the information sources. Enterprise patents were gathered from the SOOPAT retrieval system. Other financial data were derived from the CCER database. According to the above standard processing, 658 samples were finally identified as the objects in the study.
Analysis
For the statistical analysis, the Statistical Packages for the Social Science (SPSS) 19.0 window version was used. The Pearson tests were conducted to examine the effect of all dependent variables on corporate innovation ability. From Table 1 , we can see: (1) in 2012-2014, the average value in the R&D intensity of 658 samples of Listed Companies in China's gem is 6.74%, while the minimum is 0.02%, the maximum value of nearly 71.85%. That indicates that different the company's R&D intensity differences. (2) The minimum value of institutional investors' shareholding ratio is 0, and the maximum value is about 88.89%, which indicates that the preference of institutional investors is quite different. (3) The minimum of the proportion of pressure-resistance institutional investors is 0, while the maximum is 24.41% and the average is 4.47%; the minimum of the proportion of pressure-sensitive institutional investors is 0, while the maximum is 3.74%, and the average is 0.4%. That indicates that the proportion of pressure-resistance institutional investors is far greater than the pressure-sensitive institutional investors. As can be seen from Table 2 , the average of RDI of the 556 manufacturing samples is 5.84%, while that of 102 Information Technology industry samples is 11.65%. Compared to other industries, the R&D of these two industries is higher, but the difference between the two industries is also big. The median of RDI in both industries is less than the average, but the gap is not great, indicating that more than half of the company's R&D investment less.
Descriptive statistics
Correlation analysis
It can be seen from Table 3 that the correlation coefficient is small and the maximum correlation coefficient is 0.387 by the correlation test, which indicates that there is little possibility of serious multicollinearity among the variables of the model, and the rationality of the model is verified.
As can be seen from Table 3 , RDI is significantly negatively correlated with LEV and ROE at 1% level, which is significantly positively related to the overall institutional investors' proportion at 1%. There is a significant positive correlation between RDI and the proportion of pressure-resistance institutional investors at the level of 10%, but there is no significant correlation with the proportion of the pressure-sensitive institutional investors, which needs further validation through regression analysis. Remark: *, **, *** represent significant correlation at 10%, 5%, and 1% level respectively. Table 4 . Regression results of overall and classified institutional investors and R&D intensity. Remark: *, **, *** represent significant correlation at 10%, 5%, and 1% level respectively.
Result
Effect of overall investors on R&D investment intensity
The first aim of this study is to investigate the effect of overall institutional investors' proportion on firms' R&D investment intensity. According to Table 4 , F values are at the significant level of 1%, reflecting the rationality of three models. Furthermore, overall shareholders proportion and corporate R&D intensity are significantly positively correlated, t=3.153, p=0.01. Higher proportion of institutional investors' shareholding is accompanied with more corporate R&D. The result validates the hypothesis 1. Observing the regression results of each variable, the regression coefficients of the LEV and ROE are significantly negative, which shows that the debt level and income level of listed companies have negative impact. The regression coefficient of SIZE is significantly positive, reflecting that the larger company size has more R&D investments.
Effect of two types on R&D investment intensity
The second target is to explore the effects of two types of shareholders on enterprises' R&D investments intensity. According to Table 4 , the proportion of pressure-resistance institutional investors are positively correlated with the R&D intensity, t = 1.833, p = 0.1. Pressure-sensitive institutional investors and corporate R&D are negative correlated but not significant, so the pressure-sensitive institutional investors have no significant impacts on corporate R&D investment. Empirical results validate the hypothesis of 2a and 2b. The third target is to examine the two types of shareholders on enterprises' R&D investments intensity. According to Table 5 , the overall ownership of institutional investors and corporate innovation ability are significantly positively correlated, t = 1.763, p = 0.1. The data reveal that higher shareholding ratio of institutional investors are accompanied by stronger enterprise innovation ability. This result validates hypothesis 3.
Impact of overall investors on innovation capability
Impact of two types on innovation capability
The fourth target is to examine the two types of shareholders on innovation capability. The pressure-sensitive and resistant institutional investors are not significantly correlated with corporate innovation ability. Empirical results from Table 5 do not validate the hypothesis 4a, but confirming hypothesis 4b. Table 5 summarizes the regression results of the three models, there is not significant positive correlation between the current R&D intensity and the number of patent applications lags behind. LEV, ROE and corporate innovation ability have a significant positive correlation. There is a significant positive correlation between SIZE and enterprise innovation capacity, indicating that the firms of larger asset size and rate of return have stronger innovation ability. There is a significant negative correlation between FCFZ and enterprises innovation ability.
Discussion
The institutional shareholders' overall holdings ratio has the forward influence on corporate R&D and innovation ability. The finding is in line with Wahal's & Mcconnell's (2000) studies [2] . And the result indicates the positive effect of overall investors on R&D and innovation capability. Meanwhile, the reason why the regression coefficient is not high might be attributable to the weakness and limited ability of China institutional investors.
The holdings ratio of pressure-resistance institutional investors has the significant positive influence on corporate R&D. The holdings ratio of pressure-sensitive institutional investors has no significant influence on corporate R&D and innovation ability. These results are in accordance with Aghion's (2013) research [6] . However, the effect on innovation ability is not significant, opposite to previous study. The outcome may be accounted for by the facts that selected sample data are too small to fully explain the relationship between the types of institutional investor and enterprise innovation ability. It is also likely that the holding proportions of the two types of institutional investor are so low that they have weak ability to participant in corporate supervision.
